Robert Whitbourn

First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold: A Multi-Imaging Modality Study

Bernard Chevalier, Yoshinobu Onuma, Richard Rapoza, 2012, Circulation. Cardiovascular interventions.

Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes

Bernard Chevalier, Patrick W Serruys, Yoshinobu Onuma, 2010, Circulation.

Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept.

Henry Krum, R. Whitbourn, H. Krum, 2009, Hypertension.

PERFORMANCE OF THE LITHOPLASTY SYSTEM IN TREATING CALCIFIED CORONARY LESIONS PRIOR TO STENTING: RESULTS FROM THE DISRUPT CAD OCT SUB-STUDY

Akiko Maehara, Todd J. Brinton, Carlo Di Mario, 2017 .

A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.

Bernard Chevalier, Patrick W Serruys, Yoshinobu Onuma, 2010, JACC. Cardiovascular interventions.

Serial analysis of the malapposed and uncovered struts of the new generation of everolimus-eluting bioresorbable scaffold with optical coherence tomography.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2011, JACC. Cardiovascular interventions.

Comparison of in vivo acute stent recoil between the bioresorbable everolimus‐eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus‐eluting stent

Bernard Chevalier, Patrick W Serruys, Yoshinobu Onuma, 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow-up.

Bernard Chevalier, Patrick W Serruys, Richard Rapoza, 2011, JACC. Cardiovascular interventions.

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes.

Bernard Chevalier, Patrick W Serruys, Yoshinobu Onuma, 2011, Journal of the American College of Cardiology.

A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.

Patrick W Serruys, Yoshinobu Onuma, Richard Rapoza, 2011, European heart journal.

Current applications of optical coherence tomography for coronary intervention.

Patrizia Presbitero, Peter Barlis, R. Whitbourn, 2013, International journal of cardiology.

3-Dimensional optical coherence tomography assessment of jailed side branches by bioresorbable vascular scaffolds: a proposal for classification.

Joanna J Wykrzykowska, Patrick W Serruys, Yoshinobu Onuma, 2010, JACC. Cardiovascular interventions.

Improvement in timing and effectiveness of external cardiac compressions with a new non-invasive device: the CPR-Ezy.

Kim Connelly, Jenny Wilson, R. Whitbourn, 2002, Resuscitation.